0001595365-14-000001.txt : 20140108
0001595365-14-000001.hdr.sgml : 20140108
20140108135017
ACCESSION NUMBER: 0001595365-14-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20140108
DATE AS OF CHANGE: 20140108
EFFECTIVENESS DATE: 20140108
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aeglea BioTherapeutics Holdings, LLC
CENTRAL INDEX KEY: 0001595365
IRS NUMBER: 464312787
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-209533
FILM NUMBER: 14515928
BUSINESS ADDRESS:
STREET 1: 815-A BRAZOS STREET
STREET 2: #101
CITY: AUSTIN
STATE: TX
ZIP: 78701
BUSINESS PHONE: 317-429-0143
MAIL ADDRESS:
STREET 1: 815-A BRAZOS STREET
STREET 2: #101
CITY: AUSTIN
STATE: TX
ZIP: 78701
D
1
primary_doc.xml
X0707
D
LIVE
0001595365
Aeglea BioTherapeutics Holdings, LLC
815-A BRAZOS STREET
#101
AUSTIN
TX
TEXAS
78701
650-387-5294
DELAWARE
None
None
Limited Liability Company
true
2013
David
Lowe
815-A Brazos Street
#101
Austin
TX
TEXAS
78701
Executive Officer
Director
Charles
York
815-A Brazos Street
#101
Austin
TX
TEXAS
78701
Executive Officer
Henry
Skinner
815-A Brazos Street
#101
Austin
TX
TEXAS
78701
Director
Armen
Shanafelt
815-A Brazos Street
#101
Austin
TX
TEXAS
78701
Director
George
Georgiou
815-A Brazos Street
#101
Austin
TX
TEXAS
78701
Director
Biotechnology
Decline to Disclose
- 06b
false
2013-12-24
false
true
false
0
9500000
5102632
4397368
false
4
0
0
0
Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering.
false
Aeglea BioTherapeutics Holdings, LLC
/David Lowe/
David Lowe
Chief Executive Officer
2014-01-08